USFDA completes Pre-Approval Inspection at Glenmark Pharmaceuticals’ Aurangabad facility

01 Dec 2025 Evaluate

United States Food & Drug Administration (USFDA) has completed Pre-Approval Inspection at Glenmark Pharmaceuticals’ formulations manufacturing facility in Chhatrapati Sambhajinagar (Aurangabad). The inspection was carried out from November 24, 2025 to November 28, 2025, and concluded with zero 483 observations.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.


Glenmark Pharma Share Price

1976.45 2.30 (0.12%)
05-Dec-2025 11:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.05
Dr. Reddys Lab 1279.65
Cipla 1519.85
Zydus Lifesciences 932.50
Lupin 2097.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×